Clinical trial
Vancomycin Or Trimethoprim/Sulfamethoxazole for Methicillin-resistant…
NCT00324922 · University of Washington, Other · Completed
Key facts
| NCT number | NCT00324922 |
|---|---|
| Title | Vancomycin Or Trimethoprim/Sulfamethoxazole for Methicillin-resistant Staphylococcus Aureus Osteomyelitis |
| Official title | A Prospective, Randomized Trial Comparing Vancomycin With Trimethoprim/Sulfamethoxazole for the Treatment of MRSA Osteomyelitis |
| Lead sponsor | University of Washington, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Osteomyelitis, Methicillin-resistant Staphylococcus Aureus |
| Intervention type | Drug |
| Interventions | trimethoprim-sulfamethoxazole, vancomycin |
| Enrollment | 2 |
| Start date | May 1, 2006 |
| Primary completion | May 1, 2007 |
| Completion | May 1, 2007 |
| First posted | May 11, 2006 |
| Last update posted | Apr 11, 2023 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: